APPLICATION
ANDA077918
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-07
LATEST ACTION
2024-12-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
MELOXICAMPrescription
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMPrescription
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-12-23Manufacturing (CMC) · Supplement 10 · unknownAP
2024-11-21Labeling · Supplement 9 · standardAP
2024-05-29Labeling · Supplement 8 · standardAP
2019-10-22Labeling · Supplement 5 · standardAP
2019-10-22Labeling · Supplement 6 · standardAP
2013-06-12Labeling · Supplement 4 · standardAP
2010-09-10Labeling · Supplement 3AP
2009-09-24Labeling · Supplement 2AP
2009-05-27Labeling · Supplement 1AP
2006-12-07OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.